3D TECHNOLOGY APPLIED TO SURGERY

OBJECTIVE

Position France as world leader in a range of 3D technologies applied to surgery, through the development of 3D modelling of patients, secured patient data transfer systems, new 3D visualisation displays, touchless interface and augmented reality software and glasses.

PARTNERSHIP

The 3D-Surg consortium includes 3 Start-up companies (Visible Patient, Therapixel and Optinvent), 2 SME (Alioscopy and e-Media),
1 group (Altran) and two private institutes (IRCAD and IHU Strasbourg). Associated partners are Alsace Biovalley, Ecole Centrale de Nantes and Satt-Connectus representing 3 research teams of the Strasbourg University i-Cube lab.

PARTNERS

VISIBLE PATIENT

GROUPE E-MEDIA

THERAPIXEL

INSTITUTE OF IMAGE-GUIDED SURGERY

IRCAD FRANCE

ALIOSCOPY

OPTINVENT

ALTRAN

ASSOCIATED PARTNERS

ALSACE BIOVALLEY

ECOLE CENTRALE DE NANTES

SATT-CONNECTUS

UNIVERSITY OF STRASBOURG

ICUBE

5 STEPS FOR THE 3D-SURG

MARKET AND FINANCIAL ASPECT

2 billion € in 2016, with an annual 12,7% growth. 3D-Surg project aims to develop more than 12 different products in the next five years.

0billion €

in 2016

with an annual growth

0%
For more information
contact us!

and

0

different products
in the next five years

3D-Surg represents a total investment of 18M€
including 8M€ of BPI support from 2015 to 2019.

Investissements_d'avenir_-_logo

BPI France

3D-Surg is a project of the “Programme Investissements d’Avenir – PIA” of the French Government
and benefits from the financial support of the BPI France.